References
- Talaga K., Bulanda M.: Czy enterokoki oporne na wankomycynę stanowią problem w polskich szpitalach? Przegl. Epidemiol. 69, 861–864 (2015)
- Mutters N.T., Mersch-Sundermann V., Mutters R., Brandt C., Schneider-Brachert W., Frank U.: Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance. Dtsch. Arztebl. Int. 110, 725–731 (2013)
- Cetinkaya Y., Falk P., Mayhall C.G.: Vancomycin-Resistant Enterococci. Clin. Microbiol. Rev. 13, 686–707 (2000)
- Murray P.R., Rosenthal K.S., Pfaller M.A.: Mikrobiologia. Elsevier Urban & Partner, Wrocław, 2011, s. 237–240.
- Surface protein ESP [Enterococcus faecium],
https://www.ncbi.nlm.nih.gov/protein/WP_016252734.1 (29.12.2017) - Surface protein ESP [Enterococcus raffinosus],
https://www.ncbi.nlm.nih.gov/protein/WP_016250137.1 (29.12.2017) - Łysakowska M.E., Śmigielski J., Denys A.: Występowanie genów zjadliwości wśród szczepów Enterococcus faecalis izolowanych od pacjentów i ze środowiska szpitalnego. Med. Dośw. Mikrobiol. 61, 125–132 (2009)
- Comerlato C.B., de Resende M. C.C., Caierão J., d’ Azevedo P.A.: Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin. Memórias Do Instituto Oswaldo Cruz. 108, 590–595 (2013)
- Kayaoglu G, Ørstavik D.:. Virulence factors of Enterococcus faecalis: relationship to endodontic disease. Critical Reviews in Oral Biology & Medicine, 15, 308–320 (2004)
- Szczypta A., Talaga K., Bulanda M.: Enterokoki oporne na wankomycynę jako czynniki etiologiczne zakażeń związanych z opieką zdrowotną – chorobotwórczość i metody kontroli. Hygeia Public Health, 51, 134–140 (2016)
- Freitas A.R., Peixe L. i wsp.: Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids. J. Clin. Microbiol. 49, 925–931 (2011)
- Szczypa K., Wilemska J., Hryniewicz W., Sitkiewicz I.: Epidemiologia zakażeń Streptococcus pyogenes, struktura klonalna populacji, antybiotykooporność. Post. Mikrobiol. 52, 223–232 (2013)
- Homan W.L., Tribe D., Poznanski S., Li M., Hogg G., Spalburg E., van Embden J.D., Willems R.J.: Multilocus sequence typing scheme for Enterococcus faecium. J. Clin. Microbiol. 40, 1963–1971 (2002)
- Nilsson O.: Vancomycin resistant enterococci in farm animals – occurrence and importance. Infect. Ecol. Epidemiol. DOI: 10.3402/iee.v2i0.16959 (2012)
- Top J., Willems R., van der Velden S., Asbroek M., Bonten M.: Emergence of clonal complex 17 Enterococcus faecium in the Netherlands. J. Clin. Microbiol. 46, 214–219 (2008)
- Top J., Willems R., Blok H., de Regt M., Jalink K., Troelstra A., Goorhuis B., Bonten M.: Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin. Microbiol. Infect. 13, 316–319 (2007)
- Kawalec M., Pietras Z., Daniłowicz E., Jakubczak A., Gniadkowski M., Hryniewicz W., Willems R.J.: Clonal structure of Enterococcus faecalis isolated from Polish hospitals: characterization of epidemic clones. J. Clin. Microbiol. 45, 147–153 (2007)
- Miller W.R., Munita J.M., Arias C.A.: Mechanisms of antibiotic resistance in enterococci. Expert Rev. Anti-Infect. Ther. 12, 1221–1236 (2014)
- O’Driscoll T., Crank C.W.: Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect. Drug Resist. 8, 217–230 (2015)
- Horodniceanu T., Bougueleret L., El-Solh N., Bieth G., Delbos F.: High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob. Agents Chemother. 16, 686–689 (1979)
- Mederski-Samoraj B.D., Murray B.E.: High-level resistance to gentamicin in clinical isolates of enterococci. J. Infect. Dis. 147, 751–757 (1983)
- Uttley A.H., Collins C.H., Naidoo J., George R.C: Vancomycin-resistant Enterococci. Lancet, 332, 57–58 (1988)
- Żabicka D., Literacka E., Bojarska K.: MDR,XDR, PDR – jednolite, międzynarodowe definicje nabytej oporności drobnoustrojów na antybiotyki. Aktualności Narodowego Programu Ochrony Antybiotyków, 3 (2012),
http://www.antybiotyki.edu.pl/pdf/biuletyn/biuletyn_npoa_3-2012.pdf (29.12.2017) - Tomczak S., Dettlaff K., Jelińska A. Linezolid i jego analogi – perspektywy i ograniczenia terapii. Farm. Współcz. 8, 227–234 (2015)
- Gonzales R.D., DaPaul M., Schreckenberger C., Graham M.B., Swathi-Kelkar D., Besten K.D., Quinn J.P.: Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet, 357, 1179 (2001)
- Auckland C., Teare L., Cooke F., Kaufmann M.E., Warner M., Jones G., Bamford K., Ayles H., Johnson A.P.: Linezolid-resistant Enterococci: report of the first isolates in the United Kingdom. J. Antimicrob. Chemother. 50, 743–746 (2002)
- Herrero I.A., Inmaculada A., Issa N.C., Patel R.: Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. New Engl. J. Med. 346, 867–869 (2002)
- Leavis H.L., Willems R.J., Top J., Bonten M.J.: High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J. Clin. Microbiol. 44, 1059–1064 (2006)
- Lewis J.S., Owens A., Cadena J., Sabol K., Patterson J.E., Jorgensen J.H.: Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob. Agents Chemother. 49, 1664–1665 (2005)
- Montero C.I., Stock F., Murray P.R.: Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob. Agents Chemother. 52, 1167–1170 (2008)
- Guido W., Gfrörer S., Fleige C., Witte W., Klare I.: Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J. Antimicrob. Chemother. 61, 1182–1183 (2008)
- Cordina C., Hill R., Deshpande A., Hood J., Inkster T.: Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J. Antimicrob. Chemother. 67, 1806–1807 (2012)
- Żabicka D., Stefaniuk E., Hryniewicz W.: Tigecyklina – aktywność wobec Acinetobacter ssp.
http://www.korld.edu.pl/pdf/TIGECYKLINA_opracowanie_wer_ost.pdf (29.12.2017) - Ricaurte J.C., Boucher H.W., Turett G.S., Moellering R.C., Labombardi V.J., Kislak J.W.: Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. Clin. Microbiol. Infect. 7, 17–21 (2001)
- Eliakim-Raz N., Lador A., Leibovici-Weissman Y., Elbaz M., Paul M., Leibovici L. Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 70, 979–996 (2015)
- Kożuszko S., Bogiel T., Gospodarek E.: Enterococcus sp. oporne na wankomycynę. Dośw. Mikrobiol. 61, 351–357 (2009)
- Holmström K., Gräslund S., Wahlström A., Poungshompoo S., Bengtsson B., Kautsky N.: Antibiotic use in schrimp farming and implications for environmental and human health. Int. J. Food Sci. Technol. 38, 255–266 (2003).
- Chajęcka-Wierzchowska W., Zadernowska A., Łaniewska-Trokenheim Ł.: Oporność na antybiotyki bakterii z rodzaju Enterococcus występujących w żywności. Kosmos, 66, 67–79 (2017)
- Kuch A., Żabicka D., Hryniewicz W.: Rekomendacje doboru testów do oznaczania wrażliwości bakterii na antybiotyki i chemioterapeutyki 2009. Oznaczanie wrażliwości Enterococcus spp. Krajowy Ośrodek Referencyjny ds. Lekowrażliwości Drobnoustrojów.
http://www.korld.edu.pl/pdf/04-Rek2009-Enterokoki.pdf (29.12.2017) - Młynarczyk A., Grzybowska W., Mrówka A., Tyski S., Młynarczyk G.: Genetyczne podobieństwo opornych na wankomycynę szczepów Enterococcus faecium izolowanych z materiału klinicznego. Med. Dośw. Mikrobiol. 62, 297–302 (2010)
- Lebreton F., Depardieu F., Bourdon N., Fines-Guyon M., Berger P., Camiade S., Leclercq R., Courvalin P., Cattoir V.: d-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 55, 4606–4612 (2011)
- Zhu W., Murray P.R., Huskins W.C., Jernigan J.A., McDonald L.C., Clark N.C., Anderson K.F., McDougal L.K., Hageman J.C., Olsen-Rasmussen M., Frace M., Alangaden G.J., Chenoweth C., Zervos M.J., Robinson-Dunn B., Schreckenberger P.C., Reller L.B., Rudrik J.T., Patell J.B.: Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 54, 4314–4320 (2010)
- Wardal E., Markowska K., Żabicka D., Wróblewska M., Giemza M., Mik E., Połowniak-Pracka H., Woźniak A., Hryniewicz W., Sadowy E.: Molecular Analysis of VanA Outbreak of Enterococcus faecium in Two Warsaw Hospitals: The Importance of Mobile Genetic Elements. Biomed Res Int. 2014: 575367 (2014)
- Freitas A.R., Novais C., Tedim A.P., Francia M.V., Baquero F., Peixe L., Coque T.M.: Microevolutionary Events Involving Narrow Host Plasmids Influences Local Fixation of Vancomycin-Resistance in Enterococcus Populations. PLoS One. 8, e60589 (2013)
- Lim S.K., Tanimoto K., Tomita H., Ike Y.: Pheromone-responsive conjugative vancomycin resistance plasmids in Enterococcus faecalis isolates from humans and chicken feces. Appl Environ Microbiol. 72, 6544–53 (2006)
- Kelli L. Palmer K.L., Veronica N. Kos V.N., Gilmore M.S.: Horizontal Gene Transfer and the Genomics of Enterococcal Antibiotic Resistance. Current Opinion in Microbiology 13, 632–639 (2010)
- Faron M.L., Ledeboer N.A., Buchana B.W.: Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant Enterococcus in the health care setting. J. Clin. Microbiol. 54, 2436–2447 (2016)
- Hasman H., Aarestrup F.M., Dalsgaard A., Guardabassi L.: Heterologous expression of glycopeptide resistance vanHAX gene cluster from soil bacteria in Enterococcus faecalis. J. Antimicrob. Chemother. 57, 648–653 (2006)
- Depardieu F., Reynolds P.E., Courvalin P.: VanD-type vancomycin-resistant Enterococcus faecium 10/96A. Antimicrob. Agents Chemother. 47, 7–18 (2003)
- Lebel S., Bouttier S., Lambert T.: The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis. FEMS Microbiol. Lett. 238, 93–100 (2004)
- Boyd D.A., Willey B.M., Fawcett D., Gillani N., Mulvey M.R.: Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel d-Alad-Ser gene cluster, vanL. Antimicrob. Agents Chemother. 52, 2667–2672 (2008)
- Xu X., Wang M. i wsp.: vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob. Agents Chemother. 54, 4643–4647 (2010)
- Jorgensen J.H., Crawford S.A., Kelly C.C., Patterson J.E.: In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods. Antimicrob. Agents Chemother. 47, 3760–3763 (2003)
- Simner P. J., Zhanel G.G. i wsp.: Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013). Antimicrob. Agents Chemother. 59, 4315–4317 (2015)
- Zhanel G.G., Hoban D.J. i wsp.: Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob. Agents Chemother. 52, 1430–1437 (2008)
- Ravi D., Rompicherla V., Govindan G., Shanmugam P.: Speciation of enterococcal isolates in a tertiary care hospital and molecular characterisation of vancomycin resistant enterococci (VRE). Ind. J. Microbiol. Res. 3, 77–81 (2016)
- Suzuki M., Koyanoa S., Okugawa S., Okazaki M., Seki G., Moriyaa K.: Diversity of vancomycin-resistant enterococci in a low endemicity area. J. Glob. Antimicrob. Res. 2, 115–118 (2014)
- Wei L., Wu Q., Jumei Z., Weipeng G., Moutong C., Liang X., Juan W., Lianying M.: Prevalence and genetic diversity of Enterococcus faecalis isolates from mineral water and spring water in China. Front. Microbiol. DOI: 10.3389/fmicb.2017.01109 (2017)
- Sun H., Wang H., Xu Y., Jones R.N., Costello A.J., Liu Y., Li G., Chen M., Mendes R.E.: Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China. Diagn. Microbiol. Infect. Dis. 74, 399–403 (2012)
- Lai Ch.Ch., Chub Ch-Ch., Chengc A., Huang Y.T., Hsuehd P.R.: Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010. J. Microbiol. Immunol. Infect. 48, 431–436 (2015)
- Alves G.D.S., Pereira M.F., Bride L.L., Nunes A.P.F, Schuenck R.P.: Clonal dissemination of vancomycin-resistant Enterococcus faecium ST412 in a Brazilian region. Braz. J. Infect. Dis. DOI: 10.1016/j.bjid.2017.07.001 (2017)
- Ruzon F.I., de Paula S.B., Kanoshiki R.L., Pereira-Santos J., Kerbauy G., Kobayashi R.K., Yamada-Ogatta S.F.: Virulence determinants in vancomycin-resistant Enterococcus faecium vanA isolated from different sources at University Hospital of Londrina, Paraná, Brazil. J. Microbiol. 48, 814–821 (2010)
- Charakterystyka produktu leczniczego weterynaryjnego (Advocin 180),
http://www.zoetis.com.pl/global-assets/private/zoetis_com_pl_advocin_180_2013_06.pdf (29.12.2017) - Iweriebor B.C., Obi L.C., Okoh A.I.: Macrolide, glycopeptide resistance and virulence genes in Enterococcus species isolates from dairy cattle. J. Med. Microbiol. 65, 641–648 (2016)
- Akpaka P.E., Kissoon S., Jayaratne P.: Molecular analysis of vancomycin-resistant enterococci isolated from regional hospitals in Trinidad and Tobago. Adv. Med. DOI: 10.1155/2016/8762691 (2016)
- Somily A.M., Al-Mohizea M.M., Absar M.M., Fatani A.J., Ridha A.M., Al-Ahdal M.N., Senok A.C., Al-Qahtani A.A.: Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia. Microb. Pathog. 97, 79–83 (2016)
- Żabicka D.: Monitorowanie oporności w Polsce – dane sieci EARS-Net.
http://www.korld.edu.pl/pdf/Monitorowanie_dane_2016_strona_KORLD.pdf (29.12.2017) - Talaga K., Odrowąż-Konduracka D., Paradowska B., Jagiencarz-Starzec B., Wolak Z., Bulanda M., Szczypta A.: Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland. Adv. Clin. Exp. Med. 27, 111–117 (2018)
- Grzybowska W., Mlynarczyk G. et al.: Molecular epidemiology of vancomycin-resistant Enterococcus faecalis among patients of transplantology wards. Transplant. Proceed. 41, 3256–3257 (2009)
- Talaga-Ćwiertnia K., Bulanda M.: Analiza sytuacji epidemiologicznej zakażeń wankomycynoopornymi Enterococcus faecium na świcie, z uwzględnieniem obecnej sytuacji w Polsce Przegl Epidemiol 72, 3–15 (2018)
- Kucharska I., Rychlewska A.: Szpitalne ogniska epidemiczne w Polsce w 2014 roku. Warszawa 21 września 2015 r.,
http://www.antybiotyki.edu.pl/pdf/ogniskaepid3.pdf (29.12.2017) - Sadowy E., Gawryszewska I., Kuch A., Żabicka D., Hrynkiewicz W.: The changing epidemiology of VanB Enterococcus faecium in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 37, 927–936 (2018)
- Młynarczyk G., Młynarczyk A., Brzuszkiewicz E., Łuczak M.: Oporność na antybiotyki glikopeptydowe szczepów z rodzaju Enterococcus izolowanych w latach 1997–2000 w szpitalu klinicznym w Warszawie. Med. Dośw. Mikrobiol. 53, 321–330 (2001)
- Skowron K., Jeleńska A., Paluszak Z., Szala B.: Prevalence and distribution of VRE (vancomycin resistant enterococci) and VSE (vancomycin susceptible enterococci) strains in the breeding environment Ann. Agric. Environ. Med. 23, 231–236 (2016)
- Orsi G.B., Ciorba V.: Vancomycin resistant enterococci healthcare associated infections. Ann. Ig. 25, 485–492 (2013)
- Schouten M.A., Hoogkamp-Korstanje J.A., Meis J.F., Voss A., European VRE Study Group: Prevalence of vancomycin-resistant enterococci in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 19, 816–822 (2000)
- Summary of the latest data on antibiotic resistance in the European Union, EARS-Net surveillance data, November 2016,
https://ecdc.europa.eu/sites/portal/files/documents/antibiotics-EARS-Net-summary-2016_0.pdf (29.12.2017) - Kubašová I., Strompfová V., Lauková A.: Safety assessment of commensal enterococci from dogs. Folia Microbiol. (Praha), DOI: 10.1007/s12223-017-0521-z (2017).
- Remschmidt C., Schröder C., Behnke M., Gastmeier P., Geffers C., Kramer T.S.: Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance. Antimicrob. Resist. Infect. Control, 7, 54 (2018)
- Gastmeier P., Schro C., Behnke M., Meyer E., Geffers C.: Dramatic increase in vancomycin-resistant enterococci in Germany. J. Antimicrob. Chemother. 69, 1660–1664 (2014)
- Endocarditis and biofilm-associated pilus subunit A [Enterococcus faecalis 62],
https://www.ncbi.nlm.nih.gov/protein/323480330 (29.12.2017) - Gozalan A., Durmaz R. i wsp.: Molecular characterization of vancomycin-resistant Enterococcus faecium strains isolated from carriage and clinical samples in a tertiary hospital, Turkey. J. Med. Microbiol. 64, 759–766 (2015)
- Pinholt M., Gumpert H., Bayliss S., Nielsen J.B., Vorobieva V., Pedersen M., Feiln E., Worning P., Westh H.: Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark. J. Antimicrob. Chemother. 72, 40–47 (2017)